During her PhD entitled ‘neurodevelopmental disorders: a next generation’, Margot Reijnders discovered eight novel syndromes which were all published in high impact journals. After finishing her PhD in 2019 (Cum Laude), Margot Reijnders started as clinical geneticist in training at the Maastricht University Medical Center. Last year, she received personal funding to study cilia in RHEB-mutated iPSC-derived neurons and to establish a cohort of patients with rare mTORopathies, including RHEB, MTOR and RRAGC. This funding enabled her to work as a post-doc in addition to her work in clinic. Margot Reijnders is chair of the AKG board of the Vereniging Klinische Genetica Nederland (VKGN). She received several awards including the Dutch VKGN Ben ter Haar award for best research in clinical genetics in the period 2015-2020.
